Cargando…
Aptamers: A Feasible Technology in Cancer Immunotherapy
Aptamers are single-chained RNA or DNA oligonucleotides (ODNs) with three-dimensional folding structures which allow them to bind to their targets with high specificity. Aptamers normally show affinities comparable to or higher than that of antibodies. They are chemically synthesized and therefore l...
Autores principales: | Soldevilla, M. M., Villanueva, H., Pastor, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931050/ https://www.ncbi.nlm.nih.gov/pubmed/27413756 http://dx.doi.org/10.1155/2016/1083738 |
Ejemplares similares
-
Identification of TIM3 2′-fluoro oligonucleotide aptamer by HT-SELEX for cancer immunotherapy
por: Hervas-Stubbs, Sandra, et al.
Publicado: (2015) -
Aptamers: A New Technological Platform in Cancer Immunotherapy
por: Pastor, Fernando
Publicado: (2016) -
Aptamer-iRNAs as Therapeutics for Cancer Treatment
por: Soldevilla, Mario M., et al.
Publicado: (2018) -
CD28 Aptamers as Powerful Immune Response Modulators
por: Pastor, Fernando, et al.
Publicado: (2013) -
MRP1-CD28 bi-specific oligonucleotide aptamers: target costimulation to drug-resistant melanoma cancer stem cells
por: Soldevilla, Mario Martínez, et al.
Publicado: (2016)